ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
104.632,89
-0,09%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Anika Therapeutics Inc (ANIK) Börsenkurse

Anika Therapeutics Inc

Anika Therapeutics Inc (ANIK)

NASDAQ
16,31
-0,06
(-0,37%)
Geschlossen 26 Januar 10:00PM
Verzögert um 15 Minuten
16,335
0,025
(0,15%)
Nach Börsenschluss: 1:59AM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
16,31
Gebot
12,90
Fragen
16,92
Volumen
47.692
15,93 Tagesbereich 16,48
15,40 52-Wochen-Bereich 29,115
Marktkapitalisierung
238,87M
Handelsende
16,37
Handelsbeginn
16,30
Letzte Trade
99
@
16.31
Letzter Handelszeitpunkt
Finanzvolumen
US$ 780.324
VWAP
16,3617
Durchschnittliches Volumen (3 Mio.)
103.663
Ausgegebene Aktien
14.645.596
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,89
Gewinn pro Aktie (EPS)
-5,64
Erlöse
166,66M
Nettogewinn
-82,67M

Über Anika Therapeutics Inc

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerativ... Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of revenue from the United States. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
anika.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Anika Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker ANIK. The last closing price for Anika Therapeutics was US$16,37. Over the last year, Anika Therapeutics shares have traded in a share price range of US$ 15,40 to US$ 29,115.

Anika Therapeutics currently has 14.645.596 shares in issue. The market capitalisation of Anika Therapeutics is US$239,75 million. Anika Therapeutics has a price to earnings ratio (PE ratio) of -2.89.

ANIK Neueste Nachrichten

Weitere Nachrichten

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...

23 Dezember 2024
GlobeNewswire Inc.

Anika To Participate in December 2024 Investor Conferences

BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior...

22 November 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

08 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

04 November 2024
Edgar (US Regulatory)

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics PR Newswire WEST BRIDGEWATER, Mass., Oct. 31, 2024 WEST BRIDGEWATER, Mass., Oct. 31, 2024 /PRNewswire/ -- Executive...

31 Oktober 2024
PR Newswire (US)

Form 8-K - Current report

31 Oktober 2024
Edgar (US Regulatory)

Form 8-K - Current report

31 Oktober 2024
Edgar (US Regulatory)

Anika Reports Third Quarter 2024 Financial Results

Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management...

31 Oktober 2024
GlobeNewswire Inc.

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

BEDFORD, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the...

31 Oktober 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

23 Oktober 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.10.61690314620616.2117.215416.015709616.25675494CS
4-0.18-1.0915706488816.4917.215415.46620216.03062825CS
12-0.87-5.0640279394617.1818.1815.410366316.84984547CS
26-11.64-41.645796064427.9528.615.47592619.93012257CS
52-6.86-29.607250755323.1729.11515.47121022.52055623CS
156-15.42-48.597541758631.7333.1815.49346523.41540349CS
260-29.47-64.37308868545.7848.3715.410413429.99459478CS

ANIK - Frequently Asked Questions (FAQ)

What is the current Anika Therapeutics share price?
The current share price of Anika Therapeutics is US$ 16,31
How many Anika Therapeutics shares are in issue?
Anika Therapeutics has 14.645.596 shares in issue
What is the market cap of Anika Therapeutics?
The market capitalisation of Anika Therapeutics is USD 239,75M
What is the 1 year trading range for Anika Therapeutics share price?
Anika Therapeutics has traded in the range of US$ 15,40 to US$ 29,115 during the past year
What is the PE ratio of Anika Therapeutics?
The price to earnings ratio of Anika Therapeutics is -2,89
What is the cash to sales ratio of Anika Therapeutics?
The cash to sales ratio of Anika Therapeutics is 1,44
What is the reporting currency for Anika Therapeutics?
Anika Therapeutics reports financial results in USD
What is the latest annual turnover for Anika Therapeutics?
The latest annual turnover of Anika Therapeutics is USD 166,66M
What is the latest annual profit for Anika Therapeutics?
The latest annual profit of Anika Therapeutics is USD -82,67M
What is the registered address of Anika Therapeutics?
The registered address for Anika Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Anika Therapeutics website address?
The website address for Anika Therapeutics is anika.com
Which industry sector does Anika Therapeutics operate in?
Anika Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M

Foren

Foren anzeigen

Kürzlich von Ihnen besucht

NASDAQ
ANIK
Anika Therapeutics
BIT
P10KI4
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten